Growth control and ribosomopathies

Current Opinion in Genetics and Development

Volumn 23, Issue 1, 2013, Pages 63-71

  Teng, Teng ^a   Thomas, George ^a,b   Mercer, Carol A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN MDM2; PROTEIN P53; PROTEIN S6; RIBOSOME PROTEIN; RIBOSOME RNA; RIBOSOME RNA 47S; RNA 5S; RNA POLYMERASE II; UNCLASSIFIED DRUG;

5Q- SYNDROME; BIOSYNTHESIS; BLACKFAN DIAMOND ANEMIA; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARTILAGE HYPOPLASIA; CLINICAL FEATURE; DKC1 GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GROWTH REGULATION; HDM2 GENE; HUMAN; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; MANDIBULOFACIAL DYSOSTOSIS; MOLECULAR PATHOLOGY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; RIBOSOME; RIBOSOMOPATHY; RPL11 GENE; RPL5 GENE; RPS14 GENE; RPS19 GENE; RPS6 GENE; SBDS GENE; SHWACHMAN SYNDROME; TCOF1 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; BIOGENESIS; CELL CYCLE; HUMANS; MUTATION; NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; RIBOSOMES; RNA, RIBOSOMAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877927488     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.02.001     Document Type: Review

References (90)

1. Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nat Cell Biol 2000, 2:E71-E72.
2. Kondrashov N., Pusic A., Stumpf C.R., Shimizu K., Hsieh A.C., Xue S., Ishijima J., Shiroishi T., Barna M. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 2011, 145:383-397.
3. Schmidt E.V. The role of c-myc in cellular growth control. Oncogene 1999, 18:2988-2996.
4. Doudna J.A., Rath V.L. Structure and function of the eukaryotic ribosome: the next frontier. Cell 2002, 109:153-156.
5. Chakraborty A., Uechi T., Kenmochi N. Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway. Wiley Interdiscip Rev RNA 2011, 2:507-522.
6. Oskarsson T., Trumpp A. The Myc trilogy: lord of RNA polymerases. Nat Cell Biol 2005, 7:215-217.
7. Moss T. At the crossroads of growth control; making ribosomal RNA. Curr Opin Genet Dev 2004, 14:210-217.
8. Granneman S., Baserga S.J. Ribosome biogenesis: of knobs and RNA processing. Exp Cell Res 2004, 296:43-50.
9. Ciganda M., Williams N. Eukaryotic 5S rRNA biogenesis. Wiley Interdiscip Rev RNA 2011, 2:523-533.
10. Robledo S., Idol R.A., Crimmins D.L., Ladenson J.H., Mason P.J., Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008, 14:1918-1929.
11. O'Donohue M.F., Choesmel V., Faubladier M., Fichant G., Gleizes P.E. Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits. J Cell Biol 2010, 190:853-866.
12. Vlachos A., Ball S., Dahl N., Alter B.P., Sheth S., Ramenghi U., Meerpohl J., Karlsson S., Liu J.M., Leblanc T., et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008, 142:859-876.
13. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., Ball S., Tchernia G., Klar J., Matsson H., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999, 21:169-175.
14. Gazda H.T., Grabowska A., Merida-Long L.B., Latawiec E., Schneider H.E., Lipton J.M., Vlachos A., Atsidaftos E., Ball S.E., Orfali K.A., et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 2006, 79:1110-1118.
15. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Pospisilova D. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 2007, 28:1178-1182.
16. Farrar J.E., Nater M., Caywood E., McDevitt M.A., Kowalski J., Takemoto C.M., Talbot C.C., Meltzer P., Esposito D., Beggs A.H., et al. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 2008, 112:1582-1592.
17. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 2008, 83:769-780.
18. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Petrtylova K., Mihal V., Stary J., Cerna Z., Jabali Y., Pospisilova D. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Hum Mutat 2009, 30:321-327.
19. Doherty L., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Clinton C., Schneider H.E., Sieff C.A., Newburger P.E., Ball S.E., et al. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet 2010, 86:222-228.
20. Farrar J.E., Vlachos A., Atsidaftos E., Carlson-Donohoe H., Markello T.C., Arceci R.J., Ellis S.R., Lipton J.M., Bodine D.M. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 2011, 118:6943-6951.
21. Quarello P., Garelli E., Brusco A., Carando A., Mancini C., Pappi P., Vinti L., Svahn J., Dianzani I., Ramenghi U. High frequency of ribosomal protein gene deletions in Italian Diamond Blackfan anemia patients detected by Multiplex Ligation-dependent Probe Amplification (MLPA) assay. Haematologica 2012, 97:1813-1817.
22. Kuramitsu M., Sato-Otsubo A., Morio T., Takagi M., Toki T., Terui K., Wang R., Kanno H., Ohga S., Ohara A., et al. Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. Blood 2012, 119:2376-2384.
23. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., Harris N.L., Le Beau M.M., Hellstrom-Lindberg E., Tefferi A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
24. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., Raza A., Root D.E., Attar E., Ellis S.R., et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
25. Dror Y. Shwachman-Diamond syndrome. Pediatr Blood Cancer 2005, 45:892-901.
26. Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev 2011, 25:917-929.
27. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
28. Burwick N., Coats S.A., Nakamura T., Shimamura A. Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood 2012, 120:5143-5152.
29. Mason P.J., Bessler M. The genetics of dyskeratosis congenita. Cancer Genet 2011, 204:635-645.
30. Ruggero D., Grisendi S., Piazza F., Rego E., Mari F., Rao P.H., Cordon-Cardo C., Pandolfi P.P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003, 299:259-262.
31. Mochizuki Y., He J., Kulkarni S., Bessler M., Mason P.J. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A 2004, 101:10756-10761.
32. Jack K., Bellodi C., Landry D.M., Niederer R.O., Meskauskas A., Musalgaonkar S., Kopmar N., Krasnykh O., Dean A.M., Thompson S.R., et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell 2011, 44:660-666.
33. Welting T.J., van Venrooij W.J., Pruijn G.J. Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. Nucleic Acids Res 2004, 32:2138-2146.
34. Martin A.N., Li Y. RNase MRP RNA and human genetic diseases. Cell Res 2007, 17:219-226.
35. Thiel C.T., Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract Res Clin Endocrinol Metab 2011, 25:131-142.
36. Maida Y., Yasukawa M., Furuuchi M., Lassmann T., Possemato R., Okamoto N., Kasim V., Hayashizaki Y., Hahn W.C., Masutomi K. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 2009, 461:230-235.
37. Valdez B.C., Henning D., So R.B., Dixon J., Dixon M.J. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A 2004, 101:10709-10714.
38. Dixon J., Trainor P., Dixon M.J. Treacher Collins syndrome. Orthod Craniofac Res 2007, 10:88-95.
39. van Gijn D.R., Tucker A.S., Cobourne M.T. Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome. Br J Oral Maxillofac Surg 2012, 10.1016/j.bjoms.2012.09.008.
40. Dauwerse J.G., Dixon J., Seland S., Ruivenkamp C.A., van Haeringen A., Hoefsloot L.H., Peters D.J., Boers A.C., Daumer-Haas C., Maiwald R., et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011, 43:20-22.
41. Volarevic S., Stewart M.J., Ledermann B., Zilberman F., Terracciano L., Montini E., Grompe M., Kozma S.C., Thomas G. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 2000, 288:2045-2047.
42. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G.F., Bernardi R., Pandolfi P.P., Thomas G. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 2009, 11:501-508.
43. Panic L., Tamarut S., Sticker-Jantscheff M., Barkic M., Solter D., Uzelac M., Grabusic K., Volarevic S. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol Cell Biol 2006, 26:8880-8891.
44. McGowan K.A., Pang W.W., Bhardwaj R., Perez M.G., Pluvinage J.V., Glader B.E., Malek R., Mendrysa S.M., Weissman I.L., Park C.Y., et al. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 2011, 118:3622-3633.
45. Devlin E.E., Dacosta L., Mohandas N., Elliott G., Bodine D.M. A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 2010, 116:2826-2835.
46. Jaako P., Flygare J., Olsson K., Quere R., Ehinger M., Henson A., Ellis S., Schambach A., Baum C., Richter J., et al. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011, 118:6087-6096.
47. McGowan K.A., Li J.Z., Park C.Y., Beaudry V., Tabor H.K., Sabnis A.J., Zhang W., Fuchs H., de Angelis M.H., Myers R.M., et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008, 40:963-970.
48. Barlow J.L., Drynan L.F., Hewett D.R., Holmes L.R., Lorenzo-Abalde S., Lane A.L., Jolin H.E., Pannell R., Middleton A.J., Wong S.H., et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 2010, 16:59-66.
49. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., Wilson F.H., Currie T., Khanna-Gupta A., Berliner N., et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
50. Pellagatti A., Marafioti T., Paterson J.C., Barlow J.L., Drynan L.F., Giagounidis A., Pileri S.A., Cazzola M., McKenzie A.N., Wainscoat J.S., et al. Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. Blood 2010, 115:2721-2723.
51. Elghetany M.T., Alter B.P. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med 2002, 126:452-455.
52. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., Glynn E.F., Ellington L., Du C., Dixon J., et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med 2008, 14:125-133.
53. Ryan K.M., Phillips A.C., Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001, 13:332-337.
54. Dai M.S., Zeng S.X., Jin Y., Sun X.X., David L., Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004, 24:7654-7668.
55. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004, 279:44475-44482.
56. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003, 23:8902-8912.
57. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
58. Jin A., Itahana K., O'Keefe K., Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004, 24:7669-7680.
59. Duan J., Ba Q., Wang Z., Hao M., Li X., Hu P., Zhang D., Zhang R., Wang H. Knockdown of ribosomal protein S7 causes developmental abnormalities via p53 dependent and independent pathways in zebrafish. Int J Biochem Cell Biol 2011, 43:1218-1227.
60. Fumagalli S., Ivanenkov V.V., Teng T., Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 2012, 26:1028-1040.
61. Bursac S., Brdovcak M.C., Pfannkuchen M., Orsolic I., Golomb L., Zhu Y., Katz C., Daftuar L., Grabusic K., Vukelic I., et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci U S A 2012, 109:20467-20472.
62. Zhang J., Harnpicharnchai P., Jakovljevic J., Tang L., Guo Y., Oeffinger M., Rout M.P., Hiley S.L., Hughes T., Woolford J.L. Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev 2007, 21:2580-2592.
63. Oliver E.R., Saunders T.L., Tarle S.A., Glaser T. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development 2004, 131:3907-3920.
64. Donati G., Brighenti E., Vici M., Mazzini G., Trere D., Montanaro L., Derenzini M. Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J Cell Sci 2011, 124:3017-3028.
65. Horos R., Ijspeert H., Pospisilova D., Sendtner R., Andrieu-Soler C., Taskesen E., Nieradka A., Cmejla R., Sendtner M., Touw I.P., et al. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood 2012, 119:262-272.
66. Horvathova M., Ponka P., Divoky V. Molecular basis of hereditary iron homeostasis defects. Hematology 2010, 15:96-111.
67. Quigley J.G., Yang Z., Worthington M.T., Phillips J.D., Sabo K.M., Sabath D.E., Berg C.L., Sassa S., Wood B.L., Abkowitz J.L. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004, 118:757-766.
68. Johnson L.F., Levis R., Abelson H.T., Green H., Penman S. Changes in RNA in relation to growth of the fibroblast. IV. Alterations in the production and processing of mRNA and rRNA in resting and growing cells. J Cell Biol 1976, 71:933-938.
69. Gani R. The nucleoli of cultured human lymphocytes. I. Nucleolar morphology in relation to transformation and the DNA cycle. Exp Cell Res 1976, 97:249-258.
70. Moreno E., Basler K. dMyc transforms cells into super-competitors. Cell 2004, 117:117-129.
71. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
72. Barna M., Pusic A., Zollo O., Costa M., Kondrashov N., Rego E., Rao P.H., Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008, 456:971-975.
73. Barkic M., Crnomarkovic S., Grabusic K., Bogetic I., Panic L., Tamarut S., Cokaric M., Jeric I., Vidak S., Volarevic S. The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol Cell Biol 2009, 29:2489-2504.
74. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindstrom M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction. Cancer Cell 2010, 18:231-243.
75. Cmejlova J., Dolezalova L., Pospisilova D., Petrtylova K., Petrak J., Cmejla R. Translational efficiency in patients with Diamond-Blackfan anemia. Haematologica 2006, 91:1456-1464.
76. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
77. Vlachos A., Rosenberg P.S., Atsidaftos E., Alter B.P., Lipton J.M. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012, 119:3815-3819.
78. Watson K.L., Konrad K.D., Woods D.F., Bryant P.J. Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. Proc Natl Acad Sci U S A 1992, 89:11302-11306.
79. Stewart M.J., Denell R. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth. Mol Cell Biol 1993, 13:2524-2535.
80. Lin J.I., Mitchell N.C., Kalcina M., Tchoubrieva E., Stewart M.J., Marygold S.J., Walker C.D., Thomas G., Leevers S.J., Pearson R.B., et al. Drosophila ribosomal protein mutants control tissue growth non-autonomously via effects on the prothoracic gland and ecdysone. PLoS Genet 2011, 7:e1002408.
81. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., Hopkins N. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004, 2:E139.
82. MacInnes A.W., Amsterdam A., Whittaker C.A., Hopkins N., Lees J.A. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A 2008, 105:10408-10413.
83. Yoon A., Peng G., Brandenburger Y., Zollo O., Xu W., Rego E., Ruggero D. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 2006, 312:902-906.
84. Janas M.M., Wang E., Love T., Harris A.S., Stevenson K., Semmelmann K., Shaffer J.M., Chen P.H., Doench J.G., Yerramilli S.V., et al. Reduced expression of ribosomal proteins relieves microRNA-mediated repression. Mol Cell 2012, 46:171-186.
85. Hsieh A.C., Liu Y., Edlind M.P., Ingolia N.T., Janes M.R., Sher A., Shi E.Y., Stumpf C.R., Christensen C., Bonham M.J., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012, 485:55-61.
86. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
87. Stumpf C.R., Ruggero D. The cancerous translation apparatus. Curr Opin Genet Dev 2011, 21:474-483.
88. Gentilella A., Thomas G. Cancer biology: the director's cut. Nature 2012, 485:50-51.
89. Payne E.M., Virgilio M., Narla A., Sun H., Levine M., Paw B.H., Berliner N., Look A.T., Ebert B.L., Khanna-Gupta A. l-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 2012, 120:2214-2224.
90. Pospisilova D., Cmejlova J., Hak J., Adam T., Cmejla R. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007, 92:e66-e67.